Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Usmani (London, United Kingdom). Latest insights into treatment of small airways diseases. International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: Recent advances in physiological assessment of small airways diseases Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017 The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 Small airways and early origins of COPD: pathobiological and epidemiological considerations Source: Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019 Year: 2020 Mechanistic insight into the function of the microbiome in lung diseases Source: Eur Respir J, 50 (3) 1602467; 10.1183/13993003.02467-2016 Year: 2017 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 New approaches in lung imaging to characterise small airways diseases Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Gaining insights into pulmonary hypertension in respiratory diseases Source: Eur Respir J 2015; 46: 1247-1250 Year: 2015 New insights into pathogenesis of bronchiectasis Source: Annual Congress 2012 - Update on bronchiectasis Year: 2012 Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 New genetics and epigenetics insights in paediatric asthma Source: International Congress 2017 – Omics in paediatric asthma and beyond Year: 2017 Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights Source: Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021 Year: 2021 CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020 Current and new challenges in occupational lung diseases Source: Eur Respir Rev, 26 (146) 170080; 10.1183/16000617.0080-2017 Year: 2017 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Translating mechanisms to new drugs for COPD exacerbations Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015